MedPath

Droperidol

DROPERIDOL INJECTION, USP

Approved
Approval ID

147e033d-d997-4ef6-8bb5-a9ba372590b2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 20, 2023

Manufacturers
FDA

American Regent, Inc.

DUNS: 002033710

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Droperidol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0517-9702
Application NumberANDA072123
Product Classification
M
Marketing Category
C73584
G
Generic Name
Droperidol
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 20, 2023
FDA Product Classification

INGREDIENTS (4)

DROPERIDOLActive
Quantity: 2.5 mg in 1 mL
Code: O9U0F09D5X
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LACTIC ACIDInactive
Code: 33X04XA5AT
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.